184 related articles for article (PubMed ID: 32234894)
1. SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH
Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894
[TBL] [Abstract][Full Text] [Related]
2. SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Li W; Pang Y; Zhou Z; Liu S; Cheng K; Qin Q; Jia Y; Liu S
EBioMedicine; 2018 Dec; 38():57-68. PubMed ID: 30391496
[TBL] [Abstract][Full Text] [Related]
3. Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
Iguchi T; Komatsu H; Masuda T; Nambara S; Kidogami S; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
Anticancer Res; 2016 May; 36(5):2139-44. PubMed ID: 27127115
[TBL] [Abstract][Full Text] [Related]
4. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
[TBL] [Abstract][Full Text] [Related]
5. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.
Deng G; Luo Y; Zhang Y; Zhang J; He Z
Bioengineered; 2022 Feb; 13(2):2194-2206. PubMed ID: 35030977
[TBL] [Abstract][Full Text] [Related]
6. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma.
Son JA; Weon JH; Baek GO; Ahn HR; Choi JY; Yoon MG; Cho HJ; Cheong JY; Eun JW; Kim SS
J Exp Clin Cancer Res; 2023 Oct; 42(1):288. PubMed ID: 37899451
[TBL] [Abstract][Full Text] [Related]
7. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
[TBL] [Abstract][Full Text] [Related]
8. SF3B4 Depletion Retards the Growth of A549 Non-Small Cell Lung Cancer Cells via UBE4B-Mediated Regulation of p53/p21 and p27 Expression.
Kim H; Lee J; Jung SY; Yun HH; Ko JH; Lee JH
Mol Cells; 2022 Oct; 45(10):718-728. PubMed ID: 35996826
[TBL] [Abstract][Full Text] [Related]
9. Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.
Jiménez M; Urtasun R; Elizalde M; Azkona M; Latasa MU; Uriarte I; Arechederra M; Alignani D; Bárcena-Varela M; Álvarez-Sola G; Colyn L; Santamaría E; Sangro B; Rodriguez-Ortigosa C; Fernández-Barrena MG; Ávila MA; Berasain C
Nucleic Acids Res; 2019 Apr; 47(7):3450-3466. PubMed ID: 30657957
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
[TBL] [Abstract][Full Text] [Related]
12. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
[TBL] [Abstract][Full Text] [Related]
13. SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.
Shen Q; Nam SW
BMB Rep; 2018 Feb; 51(2):57-58. PubMed ID: 29397868
[TBL] [Abstract][Full Text] [Related]
14. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
17. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
18. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
20. A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.
Wang H; Zhang CZ; Lu SX; Zhang MF; Liu LL; Luo RZ; Yang X; Wang CH; Chen SL; He YF; Xie D; Xu RH; Yun JP
Hepatology; 2019 Jan; 69(1):179-195. PubMed ID: 30028541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
